Chimeric Antigen Receptor T Cells in Autoimmune Disease: Mechanistic Insights, Safety Challenges, and Trial Design ImperativesAuthorsPo‐Cheng Shih (ORCID: https://orcid.org/0000-0003-4152-9296)Hao-Yun Chen (ORCID: https://orcid.org/0009-0004-5074-2130)Su‐Boon YongChen‐Yu Wang (ORCID: https://orcid.org/0009-0002-5173-9940)Yu Feng ChangInstitutionsChina Medical University (TW)China Medical University Hospital (TW)Apex Tool Group (Taiwan) (TW)Changhua Christian Hospital (TW)Chung Shan Medical University (TW)Publication DetailsJournalInternational Journal of Rheumatic DiseasesPublished2026-04-01DOIhttps://doi.org/10.1111/1756-185x.70644Primary TopicCAR-T cell therapy researchTypearticleField-Weighted Citation Impact0.00Explore the Global Research Space Interactive Map